RenovoRx RNXT
NASDAQ RNXT
$1.56 -0.01 (-0.64%)
At close: Sep 30, 2026 · 4:00 PM EDT

RenovoRx (RNXT) Gross Profit (2025 - 2026)

Updated

RenovoRx (RNXT) recorded Gross Profit of $766,000 in Q2 2026, up 183.7% from $270,000 a year earlier and up 59.9% from the prior quarter.

Analysis

RenovoRx (RNXT) Gross Profit (2025 - 2026) Analysis & Trends

On a TTM basis, RenovoRx's Gross Profit came in at $1.67 million as of Jun 30, 2026; for FY2025, it came in at $796,000.

  • Across earlier years, Gross Profit came in at $43,000 in FY2024.
  • Per Business Quant, the preceding three quarters came in at $479,000 (Q1 2026), $210,000 (Q4 2025) and $213,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 RenovoRx 70.39 Mn 70.39 Mn 766,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 766,000.00
Mar 31, 2026 479,000.00
Dec 31, 2025 210,000.00
Sep 30, 2025 213,000.00
Jun 30, 2025 270,000.00
Mar 31, 2025 103,000.00
API Access

RenovoRx Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=RNXT&period=max&api_key=YOUR_API_KEY